BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Takikawa H, Manabe T. Primary sclerosing cholangitis in Japan--analysis of 192 cases. J Gastroenterol. 1997;32:134-137. [PMID: 9058310 DOI: 10.1007/bf01213311] [Cited by in Crossref: 74] [Cited by in F6Publishing: 21] [Article Influence: 3.1] [Reference Citation Analysis]
Number Citing Articles
1 Otsuka T, Noda T, Noguchi A, Nakamura H, Ibaraki K, Yamaoka K. Shewanella infection in decompensated liver disease: a septic case. J Gastroenterol 2007;42:87-90. [PMID: 17322999 DOI: 10.1007/s00535-006-1957-0] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 1.4] [Reference Citation Analysis]
2 Barrie A, Mourabet ME, Weyant K, Clarke K, Gajendran M, Rivers C, Park SY, Hartman D, Saul M, Regueiro M, Yadav D, Binion DG. Recurrent blood eosinophilia in ulcerative colitis is associated with severe disease and primary sclerosing cholangitis. Dig Dis Sci 2013;58:222-8. [PMID: 22855293 DOI: 10.1007/s10620-012-2329-7] [Cited by in Crossref: 20] [Cited by in F6Publishing: 16] [Article Influence: 2.2] [Reference Citation Analysis]
3 Aranake-Chrisinger J, Dassopoulos T, Yan Y, Nalbantoglu I. Primary sclerosing cholangitis associated colitis: Characterization of clinical, histologic features, and their associations with liver transplantation. World J Gastroenterol 2020;26:4126-39. [PMID: 32821074 DOI: 10.3748/wjg.v26.i28.4126] [Cited by in CrossRef: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Shorbagi A, Bayraktar Y. Primary sclerosing cholangitis--what is the difference between east and west? World J Gastroenterol. 2008;14:3974-3981. [PMID: 18609680 DOI: 10.3748/wig.3974] [Reference Citation Analysis]
5 Kumagai J, Taida T, Ogasawara S, Nakagawa T, Iino Y, Shingyoji A, Ishikawa K, Akizue N, Yamato M, Takahashi K, Ohta Y, Hamanaka S, Okimoto K, Nakamura M, Ohyama H, Saito K, Kusakabe Y, Maruoka D, Yasui S, Matsumura T, Sugiyama H, Sakai Y, Mikata R, Arai M, Katsuno T, Tsuyuguchi T, Kato N. Clinical characteristics and outcomes of primary sclerosing cholangitis and ulcerative colitis in Japanese patients. PLoS One. 2018;13:e0209352. [PMID: 30571774 DOI: 10.1371/journal.pone.0209352] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
6 Cha JM, Kim MH, Jang SJ. Early bile duct cancer. World J Gastroenterol 2007;13:3409-16. [PMID: 17659686 DOI: 10.3748/wjg.v13.i25.3409] [Cited by in CrossRef: 10] [Cited by in F6Publishing: 7] [Article Influence: 0.7] [Reference Citation Analysis]
7 Ohara H, Nakazawa T, Ando T, Joh T. Systemic extrapancreatic lesions associated with autoimmune pancreatitis. J Gastroenterol. 2007;42 Suppl 18:15-21. [PMID: 17520218 DOI: 10.1007/s00535-007-2045-9] [Cited by in Crossref: 35] [Cited by in F6Publishing: 26] [Article Influence: 2.5] [Reference Citation Analysis]
8 de Vries AB, Janse M, Blokzijl H, Weersma RK. Distinctive inflammatory bowel disease phenotype in primary sclerosing cholangitis. World J Gastroenterol. 2015;21:1956-1971. [PMID: 25684965 DOI: 10.3748/wjg.v21.i6.1956] [Cited by in CrossRef: 84] [Cited by in F6Publishing: 61] [Article Influence: 14.0] [Reference Citation Analysis]
9 Björnsson E. Small-duct primary sclerosing cholangitis. Curr Gastroenterol Rep 2009;11:37-41. [PMID: 19166657 DOI: 10.1007/s11894-009-0006-6] [Cited by in F6Publishing: 16] [Reference Citation Analysis]
10 Kamisawa T, Takuma K, Anjiki H, Egawa N, Kurata M, Honda G, Tsuruta K. Sclerosing cholangitis associated with autoimmune pancreatitis differs from primary sclerosing cholangitis. World J Gastroenterol. 2009;15:2357-2360. [PMID: 19452578 DOI: 10.3748/wjg.15.2357] [Cited by in CrossRef: 24] [Cited by in F6Publishing: 21] [Article Influence: 2.0] [Reference Citation Analysis]
11 Shorbagi A, Bayraktar Y. Primary sclerosing cholangitis--what is the difference between east and west? World J Gastroenterol. 2008;14:3974-3981. [PMID: 18609680 DOI: 10.3748/wjg.14.3974] [Cited by in CrossRef: 25] [Cited by in F6Publishing: 21] [Article Influence: 1.9] [Reference Citation Analysis]
12 Koyabu M, Uchida K, Fukata N, Kusuda T, Ikeura T, Sakaguchi Y, Yoshida K, Shimatani M, Fukui T, Matsushita M, Uemura Y, Kaibori M, Takaoka M, Nishio A, Okazaki K. Primary sclerosing cholangitis with elevated serum IgG4 levels and/or infiltration of abundant IgG4-positive plasma cells. J Gastroenterol. 2010;45:122-129. [PMID: 19760481 DOI: 10.1007/s00535-009-0130-y] [Cited by in Crossref: 17] [Cited by in F6Publishing: 13] [Article Influence: 1.4] [Reference Citation Analysis]
13 Isayama H, Tazuma S, Kokudo N, Tanaka A, Tsuyuguchi T, Nakazawa T, Notohara K, Mizuno S, Akamatsu N, Serikawa M, Naitoh I, Hirooka Y, Wakai T, Itoi T, Ebata T, Okaniwa S, Kamisawa T, Kawashima H, Kanno A, Kubota K, Tabata M, Unno M, Takikawa H; PSC guideline committee Members: Ministry of Health, Labour and Welfare (Japan) Research Project, The Intractable Hepatobiliary Disease Study Group. Clinical guidelines for primary sclerosing cholangitis 2017. J Gastroenterol. 2018;53:1006-1034. [PMID: 29951926 DOI: 10.1007/s00535-018-1484-9] [Cited by in Crossref: 20] [Cited by in F6Publishing: 10] [Article Influence: 6.7] [Reference Citation Analysis]
14 Nakamura K, Ito T, Kotoh K, Ihara E, Ogino H, Iwasa T, Tanaka Y, Iboshi Y, Takayanagi R. Hepatopancreatobiliary manifestations of inflammatory bowel disease. Clin J Gastroenterol 2012;5:1-8. [PMID: 26181867 DOI: 10.1007/s12328-011-0282-1] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
15 Walter D, Hartmann S, Herrmann E, Peveling-Oberhag J, Bechstein WO, Zeuzem S, Hansmann ML, Friedrich-Rust M, Albert JG. Eosinophilic cholangitis is a potentially underdiagnosed etiology in indeterminate biliary stricture. World J Gastroenterol. 2017;23:1044-1050. [PMID: 28246478 DOI: 10.3748/wjg.v23.i6.1044] [Cited by in CrossRef: 12] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
16 Chapman MH, Thorburn D, Hirschfield GM, Webster GGJ, Rushbrook SM, Alexander G, Collier J, Dyson JK, Jones DE, Patanwala I, Thain C, Walmsley M, Pereira SP. British Society of Gastroenterology and UK-PSC guidelines for the diagnosis and management of primary sclerosing cholangitis. Gut. 2019;68:1356-1378. [PMID: 31154395 DOI: 10.1136/gutjnl-2018-317993] [Cited by in Crossref: 55] [Cited by in F6Publishing: 35] [Article Influence: 27.5] [Reference Citation Analysis]
17 Hardacre JM, Iacobuzio-Donahue CA, Sohn TA, Abraham SC, Yeo CJ, Lillemoe KD, Choti MA, Campbell KA, Schulick RD, Hruban RH, Cameron JL, Leach SD. Results of pancreaticoduodenectomy for lymphoplasmacytic sclerosing pancreatitis. Ann Surg. 2003;237:853-8; discussion 858-9. [PMID: 12796582 DOI: 10.1097/01.sla.0000071516.54864.c1] [Cited by in Crossref: 98] [Cited by in F6Publishing: 43] [Article Influence: 5.4] [Reference Citation Analysis]
18 Nakazawa T, Naitoh I, Hayashi K, Sano H, Miyabe K, Shimizu S, Joh T. Inflammatory bowel disease of primary sclerosing cholangitis: a distinct entity? World J Gastroenterol 2014;20:3245-54. [PMID: 24696608 DOI: 10.3748/wjg.v20.i12.3245] [Cited by in CrossRef: 17] [Cited by in F6Publishing: 13] [Article Influence: 2.8] [Reference Citation Analysis]
19 Tamura S, Sugawara Y, Kokudo N. Primary sclerosing cholangitis as an intractable disease. Intractable Rare Dis Res. 2012;1:13-17. [PMID: 25343066 DOI: 10.5582/irdr.2012.v1.1.13] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
20 Kadokawa Y, Omagari K, Matsuo I, Otsu Y, Yamamoto U, Nishino T, Ohba K, Miyazaki M, Harada T, Taguchi T, Kohno S. Primary sclerosing cholangitis associated with lupus nephritis: a rare association. Dig Dis Sci 2003;48:911-4. [PMID: 12772788 DOI: 10.1023/a:1023095428321] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
21 Björnsson E, Boberg KM, Cullen S, Fleming K, Clausen OP, Fausa O, Schrumpf E, Chapman RW. Patients with small duct primary sclerosing cholangitis have a favourable long term prognosis. Gut 2002;51:731-5. [PMID: 12377815 DOI: 10.1136/gut.51.5.731] [Cited by in Crossref: 139] [Cited by in F6Publishing: 104] [Article Influence: 7.3] [Reference Citation Analysis]